Background: Androgen ablation is often used in addition to low-dose-rate brachytherapy in the treatment of prostate cancer, particularly for disease with adverse features. We report a single ...

A report into recurrent prostate cancer by ... to androgen ablation from initial responsiveness. Thus, the broader application of early microenvironment-targeting therapy will rely on the ...

Table I displays demographic, disease and treatment ... at least 90% of the prostate received) were averaged for a random sample of 25 patients each in the androgen ablation and no-androgen ...

But in others, the cancer can be aggressive and deadly. Prostate cancer that's detected early has the best chance for successful treatment. One in eight men will get prostate cancer at some point ...

AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system ... function-preserving treatment for men with prostate tumors,” AngioDynamics’ president ...

Prostate cancer is the second leading cause of ... Ultrasound Fusion–Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation, Journal of Urology (2024). DOI: 10.1097/JU.

The high-voltage pulses in IRE create permanent nanopores in membranes of cancer cells, inducing apoptotic-like cellular death in the target tissue. NanoKnife treatment involves no knives ...

less onerous and less invasive than currently available treatment options. Prostate cancer that has spread beyond its ...

The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving ...

European Union: The NanoKnife System is indicated for the ablation of prostate ... Focal minimally invasive treatment in localized prostate cancer: comprehensive review of different possible ...